The Clinical Trial for Primary Chronic Venous Insufficiency

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2009 by Sun Yat-sen University
Sponsor:
Information provided by:
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT00931424
First received: June 30, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted

June 30, 2009
June 30, 2009
January 2006
December 2015   (final data collection date for primary outcome measure)
clinical-etiology-anatomic-pathophysiologic classification system [ Time Frame: 3 month, 1 year, 3 year, 5 year, 7 year ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
  • phlebography [ Time Frame: 3 month, 1 year, 3 year, 5 year, 7 year ] [ Designated as safety issue: No ]
  • color doppler [ Time Frame: 3 month, 1 year, 3 year, 5 year, 7 year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
The Clinical Trial for Primary Chronic Venous Insufficiency
The Clinical Research of Surgery on Primary Chronic Venous Insufficiency

A multicenter Random Clinical Trial to confirm the advantage of the valve reconstructive surgery on Primary Chronic Venous Insufficiency.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Primary Chronic Venous Insufficiency
Procedure: valve reconstruction
reconstruct valve at the same time of superficial vein surgery
  • Experimental: reconstruction
    patients in this group will have both valve reconstruction and superficial vein surgery
    Intervention: Procedure: valve reconstruction
  • No Intervention: unreconstruction
    patients in this group will only have superficial vein surgery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
400
Not Provided
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • PCVI patients with III degree back flow in deep vein that is confirmed by color doppler or phlebography

Exclusion Criteria:

  • age over 70 years old
  • pregnancy
  • patients with severity arteriosclerosis obliterans, malignancy, severity disease of heart, lung or brain, and hematopathy
Both
15 Years to 70 Years
No
Contact: Shen-ming Wang, Professor +86 020 87755766-8198 shenmingwang@sohu.com
China
 
NCT00931424
2008001
Yes
wang shen-ming, The first affiliated hospital of Sun Yat-Sen university
Sun Yat-sen University
Not Provided
Study Chair: Shen-ming Wang, doctor First Affiliated Hospital, Sun Yat-Sen University
Sun Yat-sen University
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP